115 related articles for article (PubMed ID: 35638694)
1. Evaluating the conformational space of the active site of D
Tosso RD; Zarycz MNC; Schiel A; Goicoechea Moro L; Baldoni HA; Angelina E; Enriz RD
J Comput Chem; 2022 Jul; 43(19):1298-1312. PubMed ID: 35638694
[TBL] [Abstract][Full Text] [Related]
2. Combined MD/QTAIM techniques to evaluate ligand-receptor interactions. Scope and limitations.
Rojas S; Parravicini O; Vettorazzi M; Tosso R; Garro A; Gutiérrez L; Andújar S; Enriz R
Eur J Med Chem; 2020 Dec; 208():112792. PubMed ID: 32949964
[TBL] [Abstract][Full Text] [Related]
3. Conformational and electronic study of dopamine interacting with the D
Tosso RD; Parravicini O; Zarycz MNC; Angelina E; Vettorazzi M; Peruchena N; Andujar S; Enriz RD
J Comput Chem; 2020 Aug; 41(21):1898-1911. PubMed ID: 32511790
[TBL] [Abstract][Full Text] [Related]
4. Theoretical models to predict the inhibitory effect of ligands of sphingosine kinase 1 using QTAIM calculations and hydrogen bond dynamic propensity analysis.
Vettorazzi M; Menéndez C; Gutiérrez L; Andujar S; Appignanesi G; Enriz RD
J Comput Aided Mol Des; 2018 Jul; 32(7):781-791. PubMed ID: 29971548
[TBL] [Abstract][Full Text] [Related]
5. Searching the "biologically relevant"conformation of dopamine: a computational approach.
Andujar SA; Tosso RD; Suvire FD; Angelina E; Peruchena N; Cabedo N; Cortes D; Enriz RD
J Chem Inf Model; 2012 Jan; 52(1):99-112. PubMed ID: 22146008
[TBL] [Abstract][Full Text] [Related]
6. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R).
Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M
J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144
[TBL] [Abstract][Full Text] [Related]
7. 3-Chlorotyramine Acting as Ligand of the D2 Dopamine Receptor. Molecular Modeling, Synthesis and D2 Receptor Affinity.
Angelina E; Andujar S; Moreno L; Garibotto F; Párraga J; Peruchena N; Cabedo N; Villecco M; Cortes D; Enriz RD
Mol Inform; 2015 Jan; 34(1):28-43. PubMed ID: 27490860
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroisoquinolines functionalized with carbamates as selective ligands of D2 dopamine receptor.
Parravicini O; Bogado ML; Rojas S; Angelina EL; Andujar SA; Gutierrez LJ; Cabedo N; Sanz MJ; López-Gresa MP; Cortes D; Enriz RD
J Mol Model; 2017 Sep; 23(9):273. PubMed ID: 28866777
[TBL] [Abstract][Full Text] [Related]
9. Two Binding Geometries for Risperidone in Dopamine D3 Receptors: Insights on the Fast-Off Mechanism through Docking, Quantum Biochemistry, and Molecular Dynamics Simulations.
Zanatta G; Della Flora Nunes G; Bezerra EM; da Costa RF; Martins A; Caetano EW; Freire VN; Gottfried C
ACS Chem Neurosci; 2016 Oct; 7(10):1331-1347. PubMed ID: 27434874
[TBL] [Abstract][Full Text] [Related]
10. Exploring the structural basis and atomistic binding mechanistic of the selective antagonist blockade at D
Appiah-Kubi P; Olotu FA; Soliman MES
J Mol Recognit; 2021 May; 34(5):e2885. PubMed ID: 33401335
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Intramolecular Hydrogen Bond on the Active Metabolite Analogs of Leflunomide for Blocking the Plasmodium falciparum Dihydroorotate Dehydrogenase Enzyme: QTAIM, NBO, and Docking Study.
Heidarian R; Zahedi-Tabrizi M
Curr Comput Aided Drug Des; 2021; 17(3):480-491. PubMed ID: 32459610
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.
Zanatta G; Nunes G; Bezerra EM; da Costa RF; Martins A; Caetano EW; Freire VN; Gottfried C
ACS Chem Neurosci; 2014 Oct; 5(10):1041-54. PubMed ID: 25181639
[TBL] [Abstract][Full Text] [Related]
13. Exploring the different environments effect of piperine via combined crystallographic, QM/MM and molecular dynamics simulation study.
Saravanan K; Sivanandam M; Hunday G; Pavan MS; Kumaradhas P
J Mol Graph Model; 2019 Nov; 92():280-295. PubMed ID: 31425905
[TBL] [Abstract][Full Text] [Related]
14. Determination of key receptor-ligand interactions of dopaminergic arylpiperazines and the dopamine D2 receptor homology model.
Sukalovic V; Soskic V; Sencanski M; Andric D; Kostic-Rajacic S
J Mol Model; 2013 Apr; 19(4):1751-62. PubMed ID: 23300056
[TBL] [Abstract][Full Text] [Related]
15. Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations.
Samanta PN; Das KK
J Mol Graph Model; 2016 Jan; 63():38-48. PubMed ID: 26619075
[TBL] [Abstract][Full Text] [Related]
16. The role of LasR active site amino acids in the interaction with the Acyl Homoserine Lactones (AHLs) analogues: A computational study.
Ahumedo Monterrosa M; Galindo JF; Vergara Lorduy J; Alí-Torres J; Vivas-Reyes R
J Mol Graph Model; 2019 Jan; 86():113-124. PubMed ID: 30352386
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling of the dopamine D2 and serotonin 5-HT1A receptor binding modes of the enantiomers of 5-OMe-BPAT.
Homan EJ; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Sep; 7(9):1805-20. PubMed ID: 10530928
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the binding mode of flavonols with the active site of matrix metalloproteinase-9 through molecular docking and molecular dynamic simulations studies.
Pradiba D; Aarthy M; Shunmugapriya V; Singh SK; Vasanthi M
J Biomol Struct Dyn; 2018 Nov; 36(14):3718-3739. PubMed ID: 29068268
[TBL] [Abstract][Full Text] [Related]
19. New substituted aminopyrimidine derivatives as BACE1 inhibitors: in silico design, synthesis and biological assays.
Gutiérrez LJ; Parravicini O; Sánchez E; Rodríguez R; Cobo J; Enriz RD
J Biomol Struct Dyn; 2019 Jan; 37(1):229-246. PubMed ID: 29301478
[TBL] [Abstract][Full Text] [Related]
20. Testing the ability of rhodanine and 2, 4-thiazolidinedione to interact with the human pancreatic alpha-amylase: electron-density descriptors complement molecular docking, QM, and QM/MM dynamics calculations.
Devi RN; Khrenova MG; Israel S; Anzline C; Astakhov AA; Tsirelson VG
J Mol Model; 2017 Sep; 23(9):252. PubMed ID: 28780749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
